| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 50,476 | 42,760 | ||
| General and administrative | 11,876 | 12,750 | ||
| Total operating expenses | 62,352 | 55,510 | ||
| Loss from operations | -62,352 | -55,510 | ||
| Interest income | 917 | 1,241 | ||
| Other expense, net | -22 | -44 | ||
| Net loss and comprehensive loss | -61,457 | -54,313 | ||
| Earnings per share, basic | -1.16 | -1.03 | ||
| Earnings per share, diluted | -1.16 | -1.03 | ||
| Weighted average number of shares outstanding, basic | 52,859,308 | 52,779,162 | ||
| Weighted average number of shares outstanding, diluted | 52,859,308 | 52,779,162 | ||
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)